Global Research at UCSF
contact info
  • Resources
    • About the Forum
    • UCSF Programs
    • Scholars Resource Center
    • Partners Abroad
    • UCSF Affiliated Organizations
  • Admin Forum
    • Health/Insurance Forum
    • Grant Management Forum
    • Connectivity Forum
    • IRB Forum
    • Budgeting Forum
    • Shipping forum
  • Interest Group
    • Alcohol and HIV Interest
    • East Africa Interest Group >
      • Kenya Forum
      • Tanzania Forum
      • Uganda Forum
    • Global Health Economics
    • Global Hospitalists
    • Global Maternal & Newborn
    • Global Nursing
    • Global Oncology
    • Global Oral Health
    • Global Pediatrics Interest
    • Global Surgery
    • Global Vision
    • India Interest Group >
      • India/Southeast Asia
    • Infectious Disease Implementation Science
    • Diagnostics
    • Disaster Response
    • Refugee Health
    • Malaria Interest
    • Young Investigators in International Research
  • Work Group
    • UCSF East Africa Scientific Meeting
    • East Africa Office
    • Global JrFaculty
    • International Research Advisory Committee
    • Travel Health & Safety
    • GHS Alumni
  • Newsletter

Caryn Bern    

10/5/2014

0 Comments

 
Picture
Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.   Detection of congenital T. cruzi transmission is considered one of the pillars of control programs of Chagas disease. Congenital transmission accounts for 25% of new infections with an estimated 15,000 infected infants per year. Current programs to detect congenital Chagas disease in Latin America utilize microscopy early in life and serology after 6 months. These programs suffer from low sensitivity by microscopy and high loss to follow-up later in infancy. We developed a Chagas urine nanoparticle test (Chunap) to concentrate, preserve and detect T. cruzi antigens in urine for early, non-invasive diagnosis of congenital Chagas disease.
METHODOLOGY/PRINCIPAL FINDINGS:
This is a proof-of-concept study of Chunap for the early diagnosis of congenital Chagas disease. Poly N-isopropylacrylamide nano-particles functionalized with trypan blue were synthesized by precipitation polymerization and characterized with photon correlation spectroscopy. We evaluated the ability of the nanoparticles to capture, concentrate and preserve T. cruzi antigens. Urine samples from congenitally infected and uninfected infants were then concentrated using these nanoparticles. The antigens were eluted and detected by Western Blot using a monoclonal antibody against T. cruzi lipophosphoglycan. The nanoparticles concentrate T. cruzi antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%-98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%-57.26%). Chunap specificity was 96.5% (71/74 endemic, 12/12 non-endemic specimens). Particle-sequestered T. cruzi antigens were protected from trypsin digestion.  Chunap has the potential to be developed into a simple and sensitive test for the early diagnosis of congenital Chagas disease.

0 Comments



Leave a Reply.

    Author

    GlobalResearch at UCSF presents the broad scope of health research that is being conducted by UCSF researchers worldwide

    Archives

    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013

    Categories

    All
    HIV

    RSS Feed

UCSF Global Projects worldwide

Picture
Learn about UCSF Research across the globe.

UCSF Global Health Sciences (GHS)

Picture
UCSF Global Health Sciences
Our mothership.

Picture

Travel Health & Safety links

Picture

UCSF Global HUB

Picture
Compliance & logistics for global research

CTSI- Global Health Program

Picture
Tap into expertise at UCSF

✕